Palvella Therapeutics, Inc. · NASDAQ:PVLA

Frazier Life Sciences Public Fund, L.P. reported a 4.90% stake in Palvella Therapeutics, Inc. (Schedule 13G/A)

Event Jun 30, 2025 · Filed Aug 14, 2025

Frazier Life Sciences Public Fund, L.P. reported a 4.90% stake in Palvella Therapeutics, Inc., 545,504 shares, as a passive investor on Jun 30, 2025. Filed Aug 14, 2025 (Schedule 13G/A).

Stake
4.90%
Shares
545,504
Intent
Passive
What changed
Stake changed
Filed together
20 holders

The filing in full

HolderStakeShares
Frazier Life Sciences Public Fund, L.P.4.90%545,504
FHMLSP, L.P.4.90%545,504
FHMLSP, L.L.C.4.90%545,504
Frazier Life Sciences Public Overage Fund, L.P.1.50%160,856
FHMLSP Overage, L.P.1.50%160,856
FHMLSP Overage, L.L.C.1.50%160,856
Frazier Life Sciences X, L.P.0%4,730
FHMLS X, L.P.0%4,730
FHMLS X, L.L.C.0%4,730
Frazier Life Sciences XI, L.P.0.10%7,517
FHMLS XI, L.P.0.10%7,517
FHMLS XI, L.L.C.0.10%7,517
Frazier Life Sciences XII, L.P.0%3,793
FHMLS XII, L.P.0%3,793
FHMLS XII, L.L.C.0%3,793
James N. Topper0%4,730
Patrick J. Heron0%4,730
Albert Cha0%0
James Brush0%0
Daniel Estes0%0

Source

View original at SEC

Related